New Data To Be Presented At Isth Underscore Bioverativ???s Commitment To Advance Hemophilia Care Post author:Sam Post published:July 5, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Celgene's Multiple Myeloma Triplet Succeeds in Key Phase III Trial February 5, 2018 Amgen, Allergan Make History With First Cancer Biosimilar OK—Will Take on Genentech's $6 Billion Best-Seller September 14, 2017 Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017
Amgen, Allergan Make History With First Cancer Biosimilar OK—Will Take on Genentech's $6 Billion Best-Seller September 14, 2017
Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017